Publication dates

All regions

Breast Cancer Industry, September 2014 Market Reports from Top Publishers

You might be interested in: cancer, prostate cancer, medical equipment, more »


 
1-20 of about 7 900 reports for Breast Cancer

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • September 2014
  • by Global Data

... Is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body through ...

Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide

Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide

  • $ 1 490
  • Industry report
  • September 2014
  • by Renub Research

... Period due to hefty number of breast cancer cases. Worldwide breast cancer mri screening market and breast cancer ultrasound screening market are also growing year on year. Worldwide breast cancer ...

IV Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update

IV Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Iv diagnostics, inc. - Major products and services 8iv diagnostics, inc. Pipeline products by development stage 9iv diagnostics, inc. Pipeline products overview 11diagnostic assay - breast cancer ...

InSightec Ltd. - Product Pipeline Analysis, 2014 Update

InSightec Ltd. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Of brain tumors 15exablate - breast cancer - product status 16exablate - breast cancer - product description 16exablate - liver cancer - product status 17exablate - liver cancer - product ...

Mitomics Inc. - Product Pipeline Analysis, 2014 Update

Mitomics Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Genome based products to improve clinical insight and therapeutic s. Its pipeline products provide solutions for prostate cancer, breast cancer, uterine cancer, cervical cancer, ovarian cancer ...

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2014 Update

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

... Description 18microrna-based assay - breast cancer - product status 19microrna-based assay - breast cancer - product description 19microrna-based assay - chronic allograft dysfunction - product ...

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the European Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 12 800
  • Industry report
  • August 2014
  • by Venture Planning Group

... Ii. Worldwide market and technology overview a. Cancer statistics and etiology 1. breast cancer 2. Lung cancer 3. Colon and rectum cancer 4. Prostate cancer 5. Stomach cancer ...

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • August 2014
  • by Firstword Pharma

... In the areas of breast cancer, melanoma, nsclc, and renal cell carcinomaunderstand the key issues for which physicians require medical affairs team support ...

XEPTAGEN SpA - Product Pipeline Analysis, 2014 Update

XEPTAGEN SpA - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • August 2014
  • by Global Data

... M kit - product description 12ca19.9 - Igm kit - product status 13ca19.9 - Igm kit - product description 13cea - igm kit - breast cancer - product status 14cea - igm kit - breast ...

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Compass, a proprietary online reporting system that allows customers to access compass, chart, and nexcourse reports 24 hours a day. The patient resources category of genoptix provides disease state info for breast ...

About 5 300 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Breast Cancer Statistics, 2013
  • January 2013
    11 pages
  • Breast Cancer  

    Cancer  

  • United States  

    North America  

View report >

2 Companies for Breast Cancer

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.